US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Prescription Drugs Industry Forecasts - China Focus
4/15/2016 | published by: Asia Market Information & Development Company
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ...  |  read more...
USD 1,000
Prescription Drugs Companies in China
4/15/2016 | published by: Asia Market Information & Development Company
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ...  |  read more...
USD 1,800
Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
4/12/2016 | published by: TechNavio - Infiniti Research Ltd.
... tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical ...  |  read more...
USD 2,500
Blood Disease Drugs Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ...  |  read more...
USD 4,000
Mental Illness Drugs Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ...  |  read more...
USD 4,000
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
4/21/2016 | published by: IBISWorld
... blockbuster drugs lost patent exclusivity, allowing low-price generic drugs to inundate the market. As a result, many brand-name pharmaceutical manufacturers have dealt with intensifying competition from generic manufacturers, cutting into revenue growth. In the coming ...  |  read more...
USD 1,020
Finland Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... reforms, it will be a while before such changes have an impact, especially considering the weakstate of the economy. In the long term, an aging population and high per capita spending will drive demandfor high-value ...  |  read more...
USD 1,295
Mauritius Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... ageing population, as wellas high spending per capita, economic growth and political stability, will all contribute to driving thedevelopment of these markets at a significant pace. However, despite a continued rise in Mauritius' drugexports, the ...  |  read more...
USD 1,295
Mozambique Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... shown its commitment to improving thecountry's healthcare infrastructure and we expect increasing public expenditure, coupled with a highdisease burden, to continue driving the demand for medicines over the long-term. However, we note thatweak intellectual property ...  |  read more...
USD 1,295
Nigeria Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... of challenges that have previouslyled to delays in its implementation. The eventual rollout of the act will make Nigeria an attractive prospectfor multinational drugmakers over the long-term, though political and fiscal barriers limit the successfullikelihood ...  |  read more...
USD 1,295
Emerging Pharmaceuticals Industry Forecasts - China Focus
4/1/2016 | published by: Asia Market Information & Development Company
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ...  |  read more...
USD 1,000
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... through improvements to the domestic pharmaceutical industry. In turn, this will reduce its reliance on imported medicines; however, the basic capabilities of local drugmakers will make it difficult to achieve self-sufficiency in the near future, ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... to improve the situation and is implementing certain strategies to this end, the large funding gap and pre-existing structural issues will continue to hinder patients' access to essential medicines. We highlight, however, that access to ...  |  read more...
USD 1,295
Turkey Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... commercial opportunities for pharmaceutical manufacturers. Despite this positive development, cost containment measures will remain a risk, as will the political situation with neighbouring Syria and nearby Russia. Headline Expenditure Projections Pharmaceuticals: TRY20.81bn (USD7.64bn) in 2015 ...  |  read more...
USD 1,295
Hong Kong Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... rising medical costs as chronic diseases rise and tax revenues decline due to the rising dependency ratio. Similarly, healthcare delivery will be a key area of focus as the special administrative region augments the existing ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... The market size combined with an improving business environment makes the country an attractive prospect for foreign drugmakers Headline Expenditure Projections Pharmaceuticals: MXN177.3bn (USD11.2bn) in 2015 to MXN182.8bn (USD10.3bn) in 2016; +3.1% in local currency ...  |  read more...
USD 1,295
Portugal Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... for drugmakers is expected to continue over the coming years, as illustrated by recent government commitments to sustain a more balanced approach in terms of ensuring sustainable access to heath, as well as promoting competitiveness ...  |  read more...
USD 1,295
South Africa Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... supported through a variety of other driving factors including cost-containment measures and revised pricing structures. Despite the South African Department of Health's commitment to improving regulatory conditions, issues relating to consumer perceptions are set to ...  |  read more...
USD 1,295
Uganda Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... to improve the situation and is implementing certain strategies to address this, health sector inefficiencies persist and there is an absence of a sustainable, long-term plan. For Uganda, meeting treatment targets, such as the UNAIDS ...  |  read more...
USD 1,295
Ukraine Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... to the country's poor epidemiological profile. The country's pharmaceutical market will maintain strength as sluggish domestic production combined with robust and rising medical demand results in an even higher reliance on foreign healthcare investors and ...  |  read more...
USD 1,295
Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... its relatively poor prognosis for infectious diseases control. Pharmaceutical companies with drug portfolios addressing both infectious diseases and chronic diseases will see commercial opportunities arise in Uzbekistan. However, we expect that this will be moderated ...  |  read more...
USD 1,295
Venezuela Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... government in the future. The costs of such deals have been long expected and will be unlikely to be more damaging. Foreign currency controls, drug price controls, currency devaluation and delayed debt payments will continue ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... demand for healthcare services and medicines. Access to medicines will be strengthened by the continued expansion of universal healthcare in the country. However, price caps on high-value medicines and poor intellectual property protection continue to ...  |  read more...
USD 1,295
Pharmaceutical Manufacturers (NORWAY, DENMARK, ICELAND, FINLAND) - Industry Report
3/1/2016 | published by: Plimsoll Publishing Ltd.
... HANSEN A/S, INVENT FARMA EHF. and VITABALANS OY. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Manufacturers (NORWAY, DENMARK, ICELAND, FINLAND) analysis is ...  |  read more...
USD 890
Global Constipation Market Report: 2016 Edition
4/1/2016 | published by: Koncept Analytics
... significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three ...  |  read more...
USD 800
  2    4  5  6  7  8  9  10